+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Mapping Market Research Report by Type, by Indication, by Technology, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5012909
  • Report
  • April 2020
  • Region: Global
  • 192 pages
  • 360iResearch
UP TO OFF
until Jul 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Cardiac Mapping Market to Grow USD 2,486.73 Million by 2025, at a CAGR of 9.42%

FEATURED COMPANIES

  • Abbott Laboratories
  • Angiodynamics
  • Biosense Webster, Inc.
  • Biotronik
  • EP Solutions Sa
  • Lepu Medical
  • MORE
The Global Cardiac Mapping Market is expected to grow from USD 1,448.75 Million in 2019 to USD 2,486.73 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.42%.

Market Segmentation & Coverage:

This research report categorizes the Cardiac Mapping to forecast the revenues and analyze the trends in each of the following sub-markets:

The Contact Cardiac Mapping System is projected to witness the highest growth during the forecast period

On the basis of Type, the Cardiac Mapping Market is examined across Contact Cardiac Mapping System and Non-Contact Cardiac Mapping System. The Contact Cardiac Mapping System further studied across Basket Catheter Mapping System, Electroanatomical Mapping System, and Traditional Endocardial Catheter Mapping System. The Contact Cardiac Mapping System commanded the largest size in the Cardiac Mapping Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

The Atrial Fibrillation is projected to witness the highest growth during the forecast period

On the basis of Indication, the Cardiac Mapping Market is examined across Atrial Fibrillation, Atrial Flutter, and Atrioventricular Nodal Reentry Tachycardia (Avnrt). The Atrial Fibrillation commanded the largest size in the Cardiac Mapping Market in 2019, and it is expected to grow at the fastest CAGR during the forecast period.

On the basis of Technology, the Cardiac Mapping Market is examined across Cardiac Radionuclide Imaging, Magnetic Navigation System, Remote Navigation System, and Robotic Navigation System.

The Ambulatory Surgical Center is projected to witness the highest growth during the forecast period

On the basis of End User, the Cardiac Mapping Market is examined across Ambulatory Surgical Center, Diagnosis Center, and Hospital & Clinic. The Hospital & Clinic commanded the largest size in the Cardiac Mapping Market in 2019. On the other hand, the Ambulatory Surgical Center is expected to grow at the fastest CAGR during the forecast period.

The Asia-Pacific is projected to witness the highest growth during the forecast period

On the basis of Geography, the Cardiac Mapping Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is examined across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is examined across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is examined across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Cardiac Mapping Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cardiac Mapping Market including Abbott Laboratories, Acutus Medical, Angiodynamics, APN Health, LLC, Biosense Webster, Inc., Biosig Technologies, Inc., Biotronik, Boston Scientific Corporation, Coremap, EP Solutions Sa, Koninklijke Philips N.V., Lepu Medical, Medtronic PLC, and Microport Scientific Corporation.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cardiac Mapping Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cardiac Mapping Market?
2. What are the inhibiting factors and their impact analysis shaping the Global Cardiac Mapping Market during the forecast period?
3. What is the competitive position if vendors in the Global Cardiac Mapping Market?
4. How Porters Five Forces define the Global Cardiac Mapping Market landscape?
5. What are the technology trends and regulatory frameworks in the Global Cardiac Mapping Market?
6. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cardiac Mapping Market?
7. What is the competitive strategic window for opportunities in the Global Cardiac Mapping Market?
8. What are the modes and strategic moves considered suitable for entering the Global Cardiac Mapping Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • Angiodynamics
  • Biosense Webster, Inc.
  • Biotronik
  • EP Solutions Sa
  • Lepu Medical
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.2. Forecasting Methodology

3. Executive Summary
3.1. Market Outlook
3.2. Geography Outlook
3.3. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cardiac Mapping Market, By Geography
4.3. Cardiac Mapping Market, By Type
4.4. Cardiac Mapping Market, By Indication
4.5. Cardiac Mapping Market, By Technology
4.6. Cardiac Mapping Market, By End User

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Target and treat complex arrhythmia to control the ever-growing cardiac deaths
5.2.2. New product development strengthening clinical electrophysiology laboratories
5.2.3. Growing adoption of 3D cardiac mapping
5.3. Restraints
5.3.1. Limited awareness about cardiac medical devices
5.4. Opportunities
5.4.1. Potential in emerging markets due to the huge population base and rising awareness regarding new healthcare technologies
5.4.2. Incorporating rapidly advancing technology to optimize the safety and efficacy of catheters
5.5. Challenges
5.5.1. Limited adoption of advanced cardiac mapping system due to high cost of services

6. Industry Trends
6.1. Porters Five Forces Analysis
6.1.1. Threat of New Entrants
6.1.2. Threat of Substitutes
6.1.3. Bargaining Power of Customers
6.1.4. Bargaining Power of Suppliers
6.1.5. Industry Rivalry
6.2. Cumulative Impact of COVID-19
6.3. Client Customizations

7. Cardiac Mapping Market, By Type
7.1. Introduction
7.2. Contact Cardiac Mapping System
7.2.1. Basket Catheter Mapping System
7.2.2. Electroanatomical Mapping System
7.2.3. Traditional Endocardial Catheter Mapping System
7.3. Non-Contact Cardiac Mapping System

8. Cardiac Mapping Market, By Indication
8.1. Introduction
8.2. Atrial Fibrillation
8.3. Atrial Flutter
8.4. Atrioventricular Nodal Reentry Tachycardia (Avnrt)

9. Cardiac Mapping Market, By Technology
9.1. Introduction
9.2. Cardiac Radionuclide Imaging
9.3. Magnetic Navigation System
9.4. Remote Navigation System
9.5. Robotic Navigation System

10. Cardiac Mapping Market, By End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Diagnosis Center
10.4. Hospital & Clinic

11. Cardiac Mapping Market, By Americas
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Cardiac Mapping Market, By Asia-Pacific
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. South Korea
12.10. Thailand

13. Cardiac Mapping Market, By Europe, Middle East & Africa
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Vendor Ranking Analysis
14.3. Competitive Scenario
14.3.1. Merger & Acquisition
14.3.2. Agreement, Collaboration & Partnership
14.3.3. New Product Launch & Enhancement
14.3.4. Investment & Funding

15. Company Usability Profiles
15.1. Abbott Laboratories
15.2. Acutus Medical
15.3. Angiodynamics
15.4. APN Health, LLC
15.5. Biosense Webster, Inc.
15.6. Biosig Technologies, Inc.
15.7. Biotronik
15.8. Boston Scientific Corporation
15.9. Coremap
15.10. EP Solutions Sa
15.11. Koninklijke Philips N.V.
15.12. Lepu Medical
15.13. Medtronic PLC
15.14. Microport Scientific Corporation

16. Appendix
16.1. Discussion Guide
16.2. Edition Details
16.3. License Details
16.4. Pricing Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott Laboratories
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosense Webster, Inc.
  • Biosig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Coremap
  • EP Solutions Sa
  • Koninklijke Philips N.V.
  • Lepu Medical
  • Medtronic PLC
  • Microport Scientific Corporation
Note: Product cover images may vary from those shown
Adroll
adroll